NasdaqGM:ANIPPharmaceuticals
Is ANI Pharmaceuticals (ANIP) Fairly Priced After Its Board Change?
ANI Pharmaceuticals has delivered a strong share price gain over the past five years, yet the stock has recently pulled back and now screens as relatively cheap on broader valuation checks. That mix of long term strength and recent weakness is drawing attention to whether the current price still reflects a fair balance of expectations and risks.
Over the past 5 years, ANI Pharmaceuticals has returned about 149.4%, which suggests investors who stayed the course have been well rewarded despite...